Helene Depui Ekdal
Geen lopende functies
Profiel
Ms. Helene Depui Ekdal was previously employed as a Senior Director by AstraZeneca AB and a Director-Clinical Development by Egetis Therapeutics AB.
She received her graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
Eerdere bekende functies van Helene Depui Ekdal
| Bedrijven | Functie | Einde |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | 01-06-2023 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Helene Depui Ekdal
| Chalmers University of Technology | Graduate Degree |
| Handelshögskolan i Göteborg | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
